University of Arizona College of Medicine-Tucson Hematology and Medical Oncology

Topics

• Multiple Myeloma Research and Treatments 82
• Hematopoietic Stem Cell Transplantation 77
• Chemical Synthesis and Analysis 60
• Lymphoma Diagnosis and Treatment 60
• Cholangiocarcinoma and Gallbladder Cancer Studies 49
• Pancreatic and Hepatic Oncology Research 46
• Cancer Mechanisms and Therapy 44
• Immunotherapy and Immune Responses 40
• Monoclonal and Polyclonal Antibodies Research 38
• Acute Myeloid Leukemia Research 34
• Cell Adhesion Molecules Research 30
• Prostate Cancer Treatment and Research 28

Most cited

1. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.

   Lancet (London, England) · 2024 · 686 citations · Jennifer Segar

2. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.

   Hepatology (Baltimore, Md.) · 2023 · 350 citations · Rachna Shroff

3. Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 245 citations · Ana Lopez

4. Management of Locally Advanced Rectal Cancer: ASCO Guideline.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 150 citations · Aaron Scott

5. Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.

   JAMA oncology · 2021 · 418 citations · Rachna Shroff

6. SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 69 citations ·